Key features and details
- Rabbit polyclonal to SLC39A6/ZIP-6
- Suitable for: IHC-P, WB
- Reacts with: Human
- Isotype: IgG
Product nameAnti-SLC39A6/ZIP-6 antibody
See all SLC39A6/ZIP-6 primary antibodies
DescriptionRabbit polyclonal to SLC39A6/ZIP-6
Tested applicationsSuitable for: IHC-P, WBmore details
Species reactivityReacts with: Human
Predicted to work with: Mouse, Rat
- Human cervical cancer tissue.
Previously labelled as SLC39A6.
Storage instructionsShipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C long term. Avoid freeze / thaw cycle.
Storage bufferpH: 7.4
Preservative: 0.05% Sodium azide
Constituents: 50% Glycerol (glycerin, glycerine), 49% PBS
(without Mg2+ and Ca2+)
Concentration information loading...
PurityImmunogen affinity purified
Our Abpromise guarantee covers the use of ab183101 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|IHC-P||1/30 - 1/200.|
|WB||1/500 - 1/2000. Predicted molecular weight: 85 kDa.|
FunctionMay act as a zinc-influx transporter.
Tissue specificityHighly expressed in the breast, prostate, placenta, kidney, pituitary and corpus callosum. Weakly expressed in heart and intestine. Also highly expressed in cells derived from an adenocarcinoma of the cervix and lung carcinoma.
Sequence similaritiesBelongs to the ZIP transporter (TC 2.A.5) family.
Cellular localizationCell membrane.
- Information by UniProt
- Estrogen regulated protein LIV 1 6 antibody
- Estrogen-regulated protein LIV-1 antibody
- LIV 1 antibody
Anti-SLC39A6/ZIP-6 antibody (ab183101) at 1/500 dilution + lysate at 60 µg
anti Rabbit IgG - H&L (HRP) at 1/10000 dilution
Predicted band size: 85 kDa
Exposure time: 5 minutes
Immunohistochemical analysis of paraffin embedded Human cervical cancer tissue labeling SLC39A6/ZIP-6 with ab183101 at 1/30 dilution. Image on the right is treated with the synthetic peptide.
ab183101 has not yet been referenced specifically in any publications.